← Evidence map

ArticleNPJ Regenerative medicine2025

Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval.

Lalitha Soundararajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40253438